You are viewing: Australia Sleep Apnea Devices Market analysis
Part of: Sleep Apnea Devices Market (Global)

The Australia Sleep Apnea Devices Market was valued at $145.8 Million in 2025 and projected to reach to $250.4 Million by 2030, representing a compound annual growth rate of 8.0%. Australia's sleep apnea devices market is positioned for sustained expansion through 2030, supported by demographic aging, enhanced healthcare accessibility, and growing clinical recognition of sleep disorders.

Australia Sleep Apnea Devices Market Trends and Insights

  • This 8.0% compound annual growth rate reflects increasing awareness of sleep disorders across Australia and rising adoption of diagnostic and therapeutic devices.
  • Australia's healthcare infrastructure and aging population are driving demand for continuous positive airway pressure (CPAP) devices, oral appliances, and diagnostic equipment. The Australian market benefits from strong reimbursement policies and a growing prevalence of obstructive sleep apnea (OSA) among the population.
  • Australia's emphasis on preventive healthcare and early diagnosis is accelerating device uptake in both hospital and home-care settings.
  • Between 2025 and 2030, Australia is expected to see significant innovation in portable and connected sleep apnea devices, supported by digital health initiatives and improved patient compliance monitoring systems..

Key Market Statistics

  • CAGR (2025-2030) 8.0% CAGR
  • Market Size, 2025 ~USD 145.8 Million
  • Forecast, 2030 ~USD 250.4 Million
  • Country Australia

Australia Sleep Apnea Devices Market Overview

Market Valuation Growth :

Australia's sleep apnea devices market is valued at USD 145.8 million in 2025, with projections reaching USD 250.4 million by 2030, representing a strong 8.0% CAGR driven by healthcare advancement and demographic shifts.

Aging Population Driver :

Australia's rapidly aging demographic is a primary catalyst for market expansion, as sleep apnea prevalence increases significantly with age, boosting demand for diagnostic and therapeutic devices across the nation.

Healthcare Infrastructure Advantage :

Australia's robust healthcare system and high Medicare coverage rates facilitate widespread adoption of sleep apnea diagnostic equipment and CPAP devices, supporting sustained market growth through institutional and private channels.

Rising Disorder Awareness :

Increasing public and clinical awareness of sleep disorders in Australia is driving earlier diagnosis and treatment initiation, expanding the addressable patient population and creating opportunities for device manufacturers and healthcare providers.

Australia Sleep Apnea Devices Market Dynamics

  • The 8.0% CAGR reflects strong demand for both diagnostic polysomnography equipment and therapeutic devices such as CPAP machines and oral appliances.
  • Increasing investment in sleep medicine centers and home-based diagnostic solutions will further accelerate market penetration across urban and regional areas.
  • Government health initiatives and private insurance coverage improvements are expected to reduce treatment barriers and drive adoption rates among previously undiagnosed populations..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Australia's sleep apnea devices market is valued at USD 145.8 million in 2025 and will reach USD 250.4 million by 2030, representing 71.8% growth over five years.
    • Australia's 8.0% CAGR outpaces the global average of 7.6%, indicating stronger regional demand and market maturity.
    • Australia's aging demographic and high OSA prevalence are primary drivers of device adoption across CPAP, oral appliances, and diagnostic segments.
    • Australia's digital health infrastructure and reimbursement frameworks are accelerating adoption of connected and remote-monitoring sleep apnea devices.

    Sleep Apnea Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ORAL APPLIANCES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 7.6% from 2025 to 2030
    Largest Segment THERAPEUTIC DEVICES (Product)
    Market Size Base Year (Billions) ~USD 6.95 (2025)
    Revenue Forecast (Billions) ~USD 10.03 (2030)
    Segments Covered Product, Type

    Australia Sleep Apnea Devices Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Devices
    • Therapeutic Devices

    By Type

    • Accessories
    • Actigraphy Systems
    • Ambulatory Psg Devices
    • Apap Devices
    • Bpap Devices
    • Chin Restraints
    • Clinical Psg Devices
    • Communication Accessories
    • Cpap Devices
    • Cushions
    • Daytime-Nighttime Appliances
    • Facial Interfaces
    • Full-Face Masks
    • Home Sleep Testing Devices
    • Humidifier Accessories
    • Mandibular Advancement Devices
    • Masks
    • Nasal Masks
    • Nasal Pillow Masks
    • Oral Appliances
    • Other Accessories
    • Other Therapeutic Devices
    • Oximeters
    • Pap Devices
    • Power Accessories
    • Psg Devices
    • Sleep Screening Devices
    • Tongue-Retaining Devices
    • Transportation Accessories

    Target Audience

    • Medical Device Manufacturers : Manufacturers of CPAP machines, oral appliances, and diagnostic equipment need Australia-specific market data to assess market size, growth potential, and competitive dynamics for product development and commercialization decisions.
    • Healthcare Providers & Hospitals : Australian hospitals, sleep clinics, and diagnostic centers require market insights to justify capital investments in polysomnography equipment, understand patient demand trends, and optimize device procurement strategies.
    • Distributors & Importers : Medical device distributors operating in Australia need localized market forecasts and growth drivers to identify supply opportunities, negotiate supplier agreements, and plan inventory management for sleep apnea devices.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Australian healthcare technology require detailed market sizing, CAGR validation, and demographic drivers to assess portfolio companies, fund allocation, and exit potential in the sleep apnea sector.
    • Government & Policy Bodies : Australian health authorities and policy makers need market intelligence to inform reimbursement policies, healthcare funding allocation, and regulatory frameworks supporting sleep apnea diagnosis and treatment accessibility.

    Key Companies in the Australia Sleep Apnea Devices Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEINUnited StatesPublic CompanyTherapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables,
    ROSSMAX INTERNATIONAL LTDTaiwanPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    SANOFISpainPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    DANAHER CORPORATIONUnited StatesPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks,
    RESMEDUnited StatesPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyTherapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances,
    FISHER & PAYKEL HEALTHCARE LIMITEDNew ZealandPublic CompanyTherapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances,
    INSPIRE MEDICAL SYSTEMS, INC.United StatesPublic CompanyTherapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies),
    SOMNOMEDAustraliaPublic CompanyTherapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases),
    COMPUMEDICS LIMITEDAustraliaPublic CompanyDiagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring,
    BMCUnited StatesPrivate CompanyTherapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care,
    PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyTherapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks,

    HENRY SCHEIN

    Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.

    ROSSMAX INTERNATIONAL LTD

    Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.

    SANOFI

    Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.

    RESMED

    ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.

    FISHER & PAYKEL HEALTHCARE LIMITED

    Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.

    INSPIRE MEDICAL SYSTEMS, INC.

    Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.

    SOMNOMED

    SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.

    COMPUMEDICS LIMITED

    Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.

    BMC

    BMC is a United States-based private company founded in 1980 with 6,700 employees.

    PROSOMNUS SLEEP TECHNOLOGIES

    ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.

    Reasons to Buy this Report

    • Localized Market Sizing : Obtain precise valuation data specific to Australia's sleep apnea devices market with verified 2025 baseline (USD 145.8M) and 2030 forecast (USD 250.4M), enabling accurate business planning and investment decisions for the region.
    • Demographic Insights : Understand Australia's aging population dynamics and their direct correlation to sleep apnea prevalence, allowing stakeholders to identify high-opportunity patient segments and tailor market entry or expansion strategies accordingly.
    • Competitive Landscape Analysis : Gain intelligence on Australia-specific market drivers, healthcare infrastructure advantages, and regulatory environment to benchmark competitive positioning and identify gaps in device distribution, pricing, and clinical adoption.
    • Growth Trajectory Validation : Leverage the 8.0% CAGR projection to validate investment thesis, forecast revenue potential, and allocate resources effectively for product launches, partnerships, or acquisitions within the Australian healthcare device sector.
    • Strategic Market Entry : Access Australia-focused insights on awareness trends, healthcare coverage mechanisms, and adoption barriers to develop targeted go-to-market strategies, reimbursement approaches, and stakeholder engagement plans for device manufacturers and distributors.

    Frequently asked questions

    What is the current market size of sleep apnea devices in Australia?

    Australia's sleep apnea devices market is valued at USD 145.8 million in 2025 and is projected to grow to USD 250.4 million by 2030.

    What is the growth rate for sleep apnea devices in Australia?

    Australia's sleep apnea devices market is growing at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2030.

    What factors are driving growth in Australia's sleep apnea devices market?

    Key drivers include Australia's aging population, increasing OSA prevalence, strong healthcare reimbursement policies, digital health adoption, and growing patient awareness of sleep disorders.

    Which device types dominate Australia's sleep apnea market?

    CPAP devices remain the largest segment in Australia, followed by oral appliances and diagnostic equipment, with growing adoption of portable and connected devices.

    How does Australia's market growth compare to global trends?

    Australia's 8.0% CAGR exceeds the global average of 7.6%, reflecting stronger regional demand, mature healthcare infrastructure, and higher disease awareness.

    RESEARCH METHODOLOGY

    The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

    The following is a breakdown of the primary respondents:

    Sleep Apnea Devices Market

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    SOMNOmedcis AG (Germany) Country Manager
    ResMed (US) Regional Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • Primary and secondary research has determined the revenues generated by leading players operating in the sleep apnea devices market.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Global Sleep Apnea Devices Market Size: Bottom-up and Top-down Approach

    Sleep Apnea Devices Market

    Data Triangulation

    After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.

    Stakeholders

    • Senior Management
    • Sleep Laboratories, Clinics, & Hospitals
    • Home Care Settings
    • Academic & research institutes
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global sleep apnea devices market by product, age group, gender, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Get the Full Sleep Apnea Devices Market Report

    Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status